Nucleai Blog Research shows pathway to developing predictive biomarkers for immune checkpoint inhibitors

A study presented today at the International Association for the Study of Lung Cancer 2024 World Conference on Lung Cancer demonstrates a promising pathway toward developing predictive biomarkers for immune checkpoint inhibitors. In non-small cell lung cancer, immune checkpoint inhibitors offer significant promise, yet their efficacy is limited to a subset of patients. Identifying reliable predictive biomarkers is […] The post Research shows pathway to developing predictive biomarkers for immune checkpoint inhibitors appeared first on Nucleai.